Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes
Wolfgang R. Sperr(Medical University of Vienna), Peter Valent(Medical University of Vienna), A Greschniok, Birgitta Stehberger(University of Tübingen), Friedrich Wimazal, Ulrich Jäger(Medical University of Vienna), Lawrence B. Schwartz(Memorial Sloan Kettering Cancer Center), H. Semper(University of Vienna), Klaus Geißler(University of Vienna), Klaus Lechner, Johannes Drach(Vienna General Hospital), Andreas Chott(University of Vienna), J-H. Jordan(University of Vienna), Mehrdad Baghestanian(University of Vienna), Horny Hp(University of Tübingen), Michael Kundi(Medical University of Vienna)
Cited by 84
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765